Human clinical trial of 'Covaxin' begins in Odisha


Bhubaneswar, Jul 27 (IANS): The human clinical trial of India's first possible anti-Covid vaccine 'Covaxin' began at an institute here on Monday, an official said.

The human trial of the coronavirus vaccine has begun at the Institute of Medical Sciences and SUM Hospital in Bhubaneswar.

Covaxin has been administered to several volunteers, informed E.Venkat Rao, Principal Investigator of the trial process.

The volunteers went under a thorough screening procedure and several tests, he added.

SUM Hospital is one of the 12 centres selected by Indian Council of Medical Research (ICMR) for conducting phase one and two of the process.

Covaxin is being developed by Bharat Biotech in collaboration with the ICMR and the National Institute of Virology (NIV).

IMS and SUM Hospital is the only medical institute in Odisha which is conducting clinical trial of the vaccine.

  

Top Stories

Comment on this article


Leave a Comment

Title: Human clinical trial of 'Covaxin' begins in Odisha



You have 2000 characters left.

Disclaimer:

Please write your correct name and email address. Kindly do not post any personal, abusive, defamatory, infringing, obscene, indecent, discriminatory or unlawful or similar comments. Daijiworld.com will not be responsible for any defamatory message posted under this article.

Please note that sending false messages to insult, defame, intimidate, mislead or deceive people or to intentionally cause public disorder is punishable under law. It is obligatory on Daijiworld to provide the IP address and other details of senders of such comments, to the authority concerned upon request.

Hence, sending offensive comments using daijiworld will be purely at your own risk, and in no way will Daijiworld.com be held responsible.